Schizophrenia is a progressive and recurring disease characterized by multiple psychotic relapses. This slide deck covers the course, natural history and prognosis of schizophrenia. Other slides discuss the key components of non-adherence in patients with schizophrenia, highlighting the value of a support system.

This slide deck has been developed in collaboration with the former Lundbeck International Neuroscience Foundation.

Index for
slide deck

Title

Course, Natural History and Prognosis
Course, Natural History and Prognosis

This slide covers course, natural history and prognosis of Schizophrenia. Schizophrenia is a progressive and recurring disease characterized by multiple psychotic relapses.

This slide deck is schedules for update summer 2022.

file_download Download slide in HQ

Course of Schizophrenia

Course of Schizophrenia
Course of Schizophrenia
file_download Download slide in HQ
Schizophrenia is a heterogeneous disease with many dimensions
Schizophrenia is a heterogeneous disease with many dimensions
file_download Download slide in HQ
Schizophrenia: A broad range of symptoms
Schizophrenia: A broad range of symptoms

Source (slide): APA 2013, Pages 99–102; APA 2000, Page 299; Wilk et al. Neuropsychology 2005; 19 (6): 778–786, Page 778; NICE clinical guideline 178, Page 4.

Source (notes): APA 2013, Pages 99–102; APA 2000, Page 299–302; Wilk et al. Neuropsychology 2005; 19 (6): 778–786,…

file_download Download slide in HQ
Schizophrenia progression may lead to functional decline
Schizophrenia progression may lead to functional decline

Key message: Schizophrenia is a progressive and recurring disease characterized by multiple psychotic relapses. Following a relapse, patients often fail to recover to baseline health and this may lead to functional decline.

Background:

  • The majority of patients with schiz…
file_download Download slide in HQ
Typical Course of Schizophrenia
Typical Course of Schizophrenia

Review as stated on slide.

file_download Download slide in HQ

Please note, this slide builds

Key message: Many patients experience symptoms that are not fully controlled with treatment, with social withdrawal and impoverished thought being the two most common negative symptoms, and disordered thought and bizarre behavior the two mos…

file_download Download slide in HQ
Symptoms that are not fully controlled are significantly associated with impaired global functioning
Symptoms that are not fully controlled are significantly associated with impaired global functioning

Key message: In a study of patients in remission, those with residual symptoms had significantly worse global functioning that those without residual symptoms.

Background:

  • Patients (aged 18–65) in remission with and without residual symptoms were compared regarding psych…
file_download Download slide in HQ
Disorganization, a common residual symptom,1 is associated with impaired community functioning
Disorganization, a common residual symptom,1 is associated with impaired community functioning

Key message: Conceptual disorganization is a common residual symptom in patients with schizophrenia, and is a reliable predictor of several aspects of community functioning, as measured by the Life Skills Profile (which was specifically designed to assess constructs of re…

file_download Download slide in HQ
Positive symptoms of schizophrenia are inversely correlated with ability to function
Positive symptoms of schizophrenia are inversely correlated with ability to function

Key message: Increase in positive symptoms is directly correlated with a reduction in functional capacity. The correlation between positive symptoms and depression is predictive of impairment in real-world performance measures (as measured by interpersonal skills, communi…

file_download Download slide in HQ
Primary negative symptoms of schizophrenia can impact domains of functioning directly1
Primary negative symptoms of schizophrenia can impact domains of functioning directly1

Key message: Negative symptoms and cognitive deficits can cause patients functional impairment. Primary negative symptoms of schizophrenia can impact different domains of functioning directly, including interpersonal relations, use of common objects and activities, and in…

file_download Download slide in HQ
Take home points
Take home points
file_download Download slide in HQ

Related content

Novel and emerging pharmacologic treatments for Schizophrenia play_circle Video play_circle
Novel and emerging pharmacologic treatments for Schizophrenia

In this video Professor Christoph Correll discusses the challenges with available schizophrenia treatments & what clinicians should keep in mind when considering the emerging treatment options for schizophrenia.

14.11.2023 Schizophrenia
image Image Summary of high-level clinical characteristics of currently approved as well as newly emerging pharmacological treatments for schizophrenia with at least one positive placebo-controlled study
Summary of high-level clinical characteristics of currently approved as well as newly emerging pharmacological treatments for schizophrenia with at least one positive placebo-controlled study

The table summarizes the high-level clinical characteristics of the existing and newly emerging pharmacological treatments for schizophrenia with at least one positive placebo-controlled trial.

14.11.2023 Schizophrenia
image Image Neurotransmitter pathways involved in current and novel mechanism-action schizophrenia treatments
Neurotransmitter pathways involved in current and novel mechanism-action schizophrenia treatments

LDT=Laterodorsal tegmental nucleus; NAc = Nucleus Accumbens; SN = Substantia Nigra; VTA = Ventral Tegmental Area.

14.11.2023 Schizophrenia